Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Maximum Targeted Ablation of Atrial Flutter

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2007 by Lawson Health Research Institute.
Recruitment status was:  Recruiting
Information provided by:
Lawson Health Research Institute Identifier:
First received: June 21, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
Patients undergoing atrial flutter ablation will be randomized to either the standard ablation approach or voltage targeted approach. Patients will be followed for one year to assess outcome of the ablation technique

Condition Intervention Phase
Atrial Flutter
Procedure: radiofrequency catheter ablation
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Maximum Targeted Ablation of Atrial Flutter

Further study details as provided by Lawson Health Research Institute:

Study Start Date: July 2006
Estimated Study Completion Date: February 2008

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients undergoing TV-IVC isthmus ablatin for atrial flutter

Exclusion Criteria:

  • atypical atrial flutter
  • <18 years old any atrial surgery or pacemaker refusal to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00491010

Canada, Ontario
London Health Sciences Center
London, Ontario, Canada, N6A 5A5
Sponsors and Collaborators
Lawson Health Research Institute
Principal Investigator: Allan c Skanes, MD University of Western Ontario, London Health Sciences Center
  More Information Identifier: NCT00491010     History of Changes
Other Study ID Numbers: R-06-153  12266 
Study First Received: June 21, 2007
Last Updated: June 21, 2007
Health Authority: Canada: Ethics Review Committee

Keywords provided by Lawson Health Research Institute:
atrial flutter
voltage targeted

Additional relevant MeSH terms:
Atrial Flutter
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes processed this record on January 18, 2017